Fertility Treatments and Kawasaki Disease
Quick Facts
Do Fertility Treatments Increase Kawasaki Disease Risk?
Researchers from the University of Osaka and Osaka Women's and Children's Hospital examined large-scale health data in Japan and reported that some fertility-treatment exposures were associated with a higher likelihood of Kawasaki disease in children. Because the research was observational, it identifies a statistical relationship rather than a direct cause-and-effect connection.
Factors connected with infertility, pregnancy complications, parental characteristics, multiple births or differences in medical monitoring could partly explain the association. The absolute risk for any individual child also matters: a relative increase can still represent a small change when the underlying condition is uncommon. The findings therefore should not be interpreted as a reason to avoid medically indicated fertility care.
What Is Kawasaki Disease and Why Is Early Diagnosis Important?
Kawasaki disease causes inflammation of blood vessels and occurs predominantly in young children. Typical features include persistent fever, red eyes, changes of the lips or tongue, rash, swollen hands or feet and enlarged lymph nodes. Not every child develops every sign, and incomplete presentations can make diagnosis more difficult.
The principal concern is inflammation involving the coronary arteries. American Heart Association guidance recommends prompt evaluation and treatment, commonly with intravenous immunoglobulin and aspirin under specialist supervision, to reduce cardiac complications. Aspirin should not be given to a child without medical direction because its pediatric use requires careful assessment.
What Should Parents Who Used Fertility Treatment Do?
The study does not support screening healthy children solely because they were conceived using fertility treatment. Families should continue ordinary pediatric care and tell clinicians about relevant pregnancy and birth history when asked. Researchers will need to confirm the finding in other populations and determine whether any observed risk relates to a specific procedure, parental factors or pregnancy-related pathways.
A child with prolonged fever, especially alongside rash, red eyes, mouth changes or swollen extremities, should receive timely medical assessment. These symptoms have several possible causes, so clinicians must consider the complete examination and laboratory findings. Urgent evaluation is particularly important when a child appears very unwell, has breathing difficulty, is unusually drowsy or shows signs of dehydration.
Frequently Asked Questions
No causal relationship has been established. The Japanese study reports an association, and additional research is needed to separate treatment effects from parental, pregnancy and birth-related factors.
Routine screening of healthy children is not currently recommended on the basis of this finding. Parents should instead seek medical advice when a child has persistent fever or symptoms consistent with Kawasaki disease.
Yes. Prompt hospital-based treatment, generally including intravenous immunoglobulin and clinician-supervised aspirin, substantially reduces the likelihood of coronary artery complications.
References
- Medical Xpress. Certain fertility treatments associated with Kawasaki disease risk in children. September 2026.
- McCrindle BW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927-e999.
- Centers for Disease Control and Prevention. About Kawasaki Disease.